Clinical Trials for Peripheral T-cell Lymphoma
Peripheral T-cell lymphoma (PTCL) is an aggressive subtype of T-cell lymphoma affecting the peripheral lymphoid tissues in dogs and cats. It generally carries a worse prognosis than B-cell lymphoma and is more resistant to standard chemotherapy protocols. University research programs are actively investigating new chemotherapy regimens, immunotherapy, and targeted therapies through funded clinical trials.
2 active trials currently enrolling
Trials available at institutions in:
Understanding Peripheral T-cell Lymphoma in Pets
Peripheral T-cell lymphoma is an aggressive subtype of T-cell lymphoma that arises in the peripheral lymphoid tissues. It typically responds less well to standard chemotherapy protocols than B-cell forms.
Who it tends to affect
- Typical size: Affects both dogs and cats
- Typical age: Most commonly diagnosed in older animals
Can my pet join — does breed matter?
Trials typically enroll based on immunophenotype confirmation, prior treatment history, and overall health. All breeds are generally eligible.
Most trials are open to all breeds and set requirements by size, weight, age, and diagnosis instead. Our matching service checks your pet's specific details against each study's actual requirements.
Where Peripheral T-cell Lymphoma Trials Are Running
Active research locations are spread across the country. Current coverage by region:
States with active sites include: WI, MO, KS, MI. We expand the search to nearby states when there's no local match.
What Peripheral T-cell Lymphoma Trials Typically Cost
Many trials cover part or all of treatment costs. Of the 2 trials we're currently tracking for peripheral t-cell lymphoma:
The trials themselves are run by research institutions — we don't charge for them. Funding status changes as studies open and close, so we confirm current coverage when we match your pet.
What Peripheral T-cell Lymphoma Research Is Focused On
Current studies for peripheral t-cell lymphoma are exploring approaches like:
- •New chemotherapy regimens targeting T-cell disease
- •Immunotherapy and checkpoint inhibitor approaches
- •Targeted molecular therapy
- •Approaches to managing treatment resistance
How it works
Tell us about your pet
Share the diagnosis, your pet's age and size, and your location. It takes a few minutes — no account needed.
We research current trials
We check open studies against your pet's actual eligibility — diagnosis, stage, location, and prior treatment. Results come back in seconds — usually before you've closed the tab.
You get your matches
A personalized list of trials your pet may qualify for, with locations, funding status, and exactly how to enroll.
The trials themselves are free and run by research institutions. Our fee covers the research and eligibility matching — and if we don't find any matches for your pet, you don't pay.
Find trials for my pet with Peripheral T-cell Lymphoma now
Our matching service screens all 2 active Peripheral T-cell Lymphoma trials against your pet’s specific profile — age, breed, stage, and location.
$7 to see your matches · $23 only if trials are found
Check My Pet’s Eligibility Now →Find Trials for Your Pet
Our free matching service screens 100 active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet